You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 3, March 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intra-arterial Chemotherapy

A Welcome New Idea for the Management of Adenocystic Carcinoma of the Lacrimal Gland

Arch Ophthalmol. 1998;116:372-373.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ADENOCYSTIC CARCINOMA is an aggressive disease with a propensity for perineural, hematogenous, and lymphatic invasion. The prognosis is grim: approximately 70% to 80% of patients succumb to the disease within 10 years of diagnosis despite aggressive and often disfiguring treatment, and recurrences can occur 15 or 20 years after excision, making true cures extremely rare.1-2

Radical orbitectomy for adenoid cystic carcinoma is advocated by many orbital specialists. This disfiguring operation involves removing the orbital contents en bloc along with various amounts of orbital bone.3-4 More recent publications have recommended eye-sparing procedures.4-5 Comparison of survival rates for radical vs eye-sparing procedures has failed to demonstrate improved survival with more radical surgery.1-5 Complete surgical excision of adenocystic carcinoma of the lacrimal gland is difficult to achieve even with radical surgery. In fact, the most common site of recurrence of adenocystic carcinoma of the lacrimal gland is local.1 Complex regional anatomy, an infiltrative . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Neoadjuvant Intracarotid Chemotherapy for Treatment of Advanced Adenocystic Carcinoma of the Lacrimal Gland
Melissa L. Meldrum, David T. Tse, and Pasquale Benedetto
Arch Ophthalmol. 1998;116(3):315-321.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chemoreduction With Topical Mitomycin C Prior to Resection of Extensive Squamous Cell Carcinoma of the Conjunctiva
Shields et al.
Arch Ophthalmol 2005;123:109-113.
FULL TEXT  

Adenoid Cystic Carcinoma of the Lacrimal Gland Simulating a Dermoid Cyst in a 9-Year-Old Boy
Shields et al.
Arch Ophthalmol 1998;116:1673-1676.
ABSTRACT | FULL TEXT  

Inappropriate Use of the Term "Adenocystic" to Refer to "Adenoid Cystic" Carcinoma of the Lacrimal Gland
White
Arch Ophthalmol 1998;116:1698-1698.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.